D

Biomerica, Inc. BMRA

$1.68 -$0.03-1.75% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$1.66$1.71
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

BMRA Rating

Reward
Risk

BMRA Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

BMRA Company Overview

Biomerica, Inc. is a U.S.-based biomedical technology company focused on the development, manufacturing, and commercialization of diagnostic products used for the detection and monitoring of gastrointestinal diseases, food sensitivities, diabetes, and other medical conditions. The company operates primarily within the in vitro diagnostics (IVD) and medical technology industries, supplying products to hospitals, clinical laboratories, physicians’ offices, and over-the-counter consumer markets. Its revenue is generated through the sale of diagnostic test kits, analyzers, and related laboratory products distributed domestically and internationally.

The company’s principal business lines include gastrointestinal diagnostic testing, food intolerance testing, diabetes monitoring technologies, and clinical laboratory products. Biomerica is particularly known for its proprietary gastrointestinal diagnostic platform marketed under the InFoods® brand, which is designed to identify foods associated with symptoms of irritable bowel syndrome (IBS). The company also manufactures rapid diagnostic products and medical devices for third-party distributors and private-label partners. Founded in 1971 and headquartered in Irvine, California, Biomerica evolved from a diagnostics supplier into a broader developer of specialized diagnostic technologies with a focus on chronic digestive and metabolic disorders.

Data compiled by narrative technology. May contain errors.
Sector

BMRA Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

BMRA Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

BMRA Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

BMRA Price History

Loading...
52-Week Range13% of range
Current
$1.68
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

BMRA Valuation

Market Cap
Market Cap Rank
#15,256
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

BMRA Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

BMRA Corporate Info

Phone Number
949 645 2111
Address
17571 Von Karman Avenue
Irvine, CA 92614
Country
Year Founded

BMRA Filings

Filing Date
Thursday, October 15, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Jan 11 and 15 (est)

BMRA Headlines

9/1/2026 - SeekingAlpha.com: All News
8/27/2026 - SeekingAlpha.com: All News
8/27/2026 - Seeking Alpha - Healthcare